Sign in
4

Changes in Ownership

Gain Therapeutics, Inc. Filed Acc 0001493152-24-013983

Options or other derivatives

  • Chief Financial Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Mack Gene Chief Financial Officer 2024-04-08 Grant or award · Employee Stock Option (right to buy) +200,000 200,000 D: show line 1 in the form
Loading xslF345X05/ownership.xml…